The 2016 Lasker-DeBakey Clinical Medical Research Award: Innovative hepatitis C virus(HCV) replicons

• 作 者: Qinjian Zhao Ningshao Xia
• 机 构: State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Public Health, Xi
• 出 处: Science China(Life Sciences)
• 发表日期: 2016年11期
• 关键词: translational bringing reality replication ribavirin antiviral sector discipline

The 2016 Lasker-DeBakey Clinical Medical Research Award was given to three scientists working on different stages of the translational sciences on bringing a high efficacious therapy against hepatitis C virus(HCV)infection to a reality.An effective treatment of HCV chronic infection was developed,by a team led by Michael Sofia,using a

The 2016 Lasker-DeBakey Clinical Medical Research Award was given to three scientists working on different stages of the translational sciences on bringing a high efficacious therapy against hepatitis C virus (HCV) infection to a reality. Effective treatment of HCV chronic infection was developed, by a team led by Michael Sofia, using a